SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
Clinical trial NCT05136287 · COMPLETED
Trial details
- NCT number
- NCT05136287
- Sponsor
- Jose Seijas Amigo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-11-15
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.